On May 7, 2024 UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, reported that it will present at the following investor conferences in May (Press release, UroGen Pharma, MAY 7, 2024, View Source [SID1234642801]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citizens JMP Life Sciences Conference – May 14, 2024
Fireside Chat: May 14, 2024 at 10:00am ET
Location: New York, NY
Webcast Registration Link: Here

H.C. Wainwright BioConnect Conference – May 20, 2024
Fireside Chat: May 20, 2024 at 9:00am ET
Location: New York, NY
Webcast Registration Link: Here